Effectiveness of a selected oral serratiopeptidase in the market in reduction of the lower limb girth of patients with lower limb swelling due to cellulitis

Effectiveness of Oral Serratiopeptidase in Reduction of Lower Limb Cellulitis: A randomized controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2020/008

Enrollment

Unknown

Registered

2020-02-11

Start date

2020-02-11

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cellulitis

Interventions

All consecutive patients who are admitted to the National Hospital Sri Lanka ward 27 and 38 with lower limb cellulitis will be recruited according to inclusion / exclusion criteria. Patients will be a

Eligibility

Inclusion criteria

Inclusion criteria: • Both males and females • Above 18 years of age • Diagnosed with lower limb cellulitis

Exclusion criteria

Exclusion criteria: • Patients who are on anti-coagulants • Patients with other significant co-morbidities – congestive heart failure, chronic renal impairment • Patients who have received antibiotics during this episode prior to this admission. • Patients with preexisting lymphedema • Patients who are hypersensitive to penicillin and / or cloxacillin • Patients who present with septic shock

Design outcomes

Primary

Measure	Time frame
Limb circumference will be measured on admission using a tape measurement method [On admission, day 3 and 10 days after admission. ]	—

Secondary

Measure	Time frame
None []	—

Countries

Sri Lanka

Contacts

Public ContactNadun Lakshitha Mohotti

Doctor

nadun1983@gmail.com0112691111

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026